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Background:  Depression is debilitating and highly prevalent among adults with multiple 
sclerosis (MS).  Exercise may reduce symptoms of depression; however, the different biases 
present in uncontrolled studies could overestimate, or underestimate, noted treatment effects.  
Aim:  To review the available evidence for the effectiveness of exercise training targeted to 
MS based on the ‘gold’ standard randomised controlled trial.  Methods: Fifteen independent 
studies, comprising a pooled sample of 544 adults with relapsing-remitting or progressive 
MS, were identified from the Cochrane Library, Embase, PEDro, PsycINFO, and PubMed 
databases.  The methodological quality of included studies was assessed with the PEDro 
scale.  Hedges’ g, fail-safe Ns, heterogeneity, and p-values were calculated using random 
effects modelling.  The moderating effects of exercise type (aerobic vs. nonaerobic), exercise 
volume (i.e., total number of sessions), and baseline depression scores were additionally 
examined.  Results:  Most studies reported adequate methodological details, although 
blinding of participants and administering therapists were criteria unfulfilled.  Exercise 
programs resulted in immediate and large improvements in mood (g = .79, 95% CI [.39, 
1.19], p < .01).  However, conclusions could not be drawn for longer-term effectiveness (g = 
-.18, 95% CI [-.50, .14], p = .28; Nstudies = 4).  Univariate meta-regressions revealed a 
significant moderating effect for exercise volume.  Depressed adults who took part in 
exercise programs also displayed significantly greater improvements than controls.  
Conclusion: Exercise efficacy for post-MS depression can be maximised by bolstering 
session volume and duration for those who are most prone to respond.  The influence of 
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Multiple Sclerosis: Aetiology, Epidemiology, Symptomology  
Multiple sclerosis (MS) is an inflammatory disease that affects the brain and spinal 
cord.  Pathogenically, MS is triggered by an auto-immune response whereby lymphocytic 
immune cells infiltrate the central nervous system (CNS), via the blood brain barrier, to 
attack the protective myelin sheath that surrounds the axons of nerve cells (Hemmer et al., 
2015; Høglund & Maghazachi, 2014).  Myelin damage, or demyelination, inhibits the ability 
of nerve cells to conduct messages across the nervous system which in turn, impairs motor, 
sensory, and cognitive functions (Australian Bureau of Statistics, 2012; Høglund & 
Maghazachi, 2014; McCabe, 2012; Warren & Warren, 2001).  Widespread demyelination 
leads to chronic neurodegeneration and clinically presents as progressive accumulation of 
disability (Compston & Coles, 2008).   
MS is one of the most common forms of disability, affecting more than 2.3 million 
people worldwide and approximately 25,607 people in Australia (Browne et al., 2014; 
Campbell et al., 2019).  The precise aetiology of MS remains unknown.  Rather, a range of 
environmental and genetic risk factors have been implicated in the disease process, including 
genetic predisposition (e.g., human leukocyte antigen gene), Epstein-Barr virus contraction, 
sedentary or unhealthy lifestyle behaviours (e.g., vitamin D deficiency, cigarette smoking, 
obesity), and geographical location (i.e., residing in higher latitudes; Amato et al., 2017; 
Simpson et al., 2019).  Female gender is also a risk: women are three times more likely to be 
diagnosed with MS than men (Howard & Younger, 2016; Ribbons et al., 2017). 
The burden of MS is exacerbated by the young age of onset, with most people 
diagnosed between the ages of 20 and 40: during their most active and productive years of 
life (Amato et al., 2017; Multiple Sclerosis Australia, 2017).  A high proportion of this group 
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subsequently report unemployment, or lower workforce participation due to MS-related 
impairment or disability (Multiple Sclerosis Research Australia, 2018).  Indeed, lost wages 
and productivity remain one of the largest economic costs in MS care (Multiple Sclerosis 
Research Australia, 2018).   
The clinical symptoms of MS are diverse and depend on the location and severity of 
myelin damage in the CNS.  Somatic and cognitive features include, but are not limited to, 
paraesthesia (tingling sensation), numbness, visual impairment, gait (walking) disturbance, 
spasticity (i.e., loss of muscle control), speech difficulty, fatigue, impaired coordination and 
balance, and reduced concentration and memory (Milo & Miller, 2014).  Lhermitte’s sign 
(trigger of an electric shock sensation that moves down the spine or limbs upon neck flexion) 
and Uhthoff’s phenomenon (temporary exacerbation of symptoms when body temperature 
increases), also present in persons with MS (Compston & Coles, 2008).   
Clinical Course 
Although the pattern of MS presentation is highly variable, with symptoms 
fluctuating and even progressing, four disease courses have been identified.  Relapsing-
remitting MS (RRMS) is the most common, affecting 85% of all cases (Klineova & Lublin, 
2018).  RRMS is characterised by acute relapses of neurologic dysfunction and alternates 
with periods of remission and clinical stability (Confavreux et al., 2000; Klineova & Lublin, 
2018; Lublin & Reingold, 1996).  Although relapse frequency varies, persons with MS rarely 
experience more than two episodes per year (Compston & Coles, 2008).  Symptom recovery 
during remission phases suggests remyelination (Chari, 2007); although, relapse recovery 
becomes incomplete over time, leading to stepwise accrual of dysfunction (Compston & 
Coles, 2008; Lublin et al., 2003).  When recovery is incomplete and symptoms steadily 
worsen, the patient has entered the secondary-progressive course of MS (SPMS; Lublin & 
Reingold, 1996).  SPMS affects approximately 65% of the MS population, occurring an 
EXERCISE AND DEPRESSION IN MULTIPLE SCLEROSIS 
 
3 
average of 19 years after RRMS onset (Compston & Coles, 2008; Rovaris et al., 2006).  
Earlier progression to SPMS has been associated with male gender and older age at diagnosis 
(Klineova & Lublin, 2018).  Primary-progressive MS (PPMS) is rare, affecting 10% to 20% 
of patients (Compston & Coles, 2008).  PPMS is characterised by continued disease 
progression from onset with minor fluctuations (including lack of initial relapse-remitting 
phase), but no distinct relapses (Lublin & Reingold, 1996).  Finally, clinically isolated 
syndrome (CIS) involves an acute episode of demyelination.  Many who experience CIS will 
not develop a second relapse.  However, the chance of a second inflammatory attack, and 
subsequent MS diagnosis, increases from 50% at two years, to 82% at 20 years if CIS is 
accompanied by white matter lesions (Fisniku et al., 2008). 
Diagnosis and Prognosis 
MS is diagnosed according to the number of clinical attacks, lesions, and their 
dissemination across space and time in the CNS (McDonald et al., 2001; Poser et al., 1983; 
Thompson et al., 2018).  Clinical evidence is obtained by magnetic resonance imaging 
(MRI), laboratory samples (e.g., cerebral spinal fluid to identify an increase in 
immunoglobulin concentrations), and/or an assessment of medical history.  Although 
advances in medical treatment and care over the last 20 years have improved life expectancy, 
those with MS can expect to live at least 7 years fewer than others without the disease 
(Marrie et al., 2015).  The prognosis is better for those with relapsing-remitting, rather than 
progressive forms of the disease, likely due to the availability of disease-modifying 
medications.  Conversely, late onset of disease (i.e., > 40 years of age at onset of symptoms) 
and a high frequency of relapses predict poor prognosis (Confavreux et al., 1980).   
Depression and MS  
The variety of disabling physical, sensory, and cognitive symptoms that characterise 
MS have a profound effect on psychological functioning.  Persons with MS have a high 
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prevalence of psychiatric symptoms and disorders, with major depressive disorder (MDD; 
Milo & Miller, 2014) being one of the most debilitating comorbidities.  Depressive disorder 
is characterised by the presence of low mood, accompanied by somatic and cognitive changes 
that significantly impair everyday functioning (American Psychiatric Association, 2013).  
Rates of depressive disorder among adults living with MS range from 19% to 54% (Goldman 
Consensus Group, 2005; Marrie et al., 2009; Raskind, 2008): a stark contrast to the lifetime 
rate of 11% estimated in the general population (Lim et al., 2018).  A further 50% report 
depressive symptoms of concern, such as feelings of worthlessness and guilt, thoughts of 
suicide, and loss of interest in day-to-day activities (Chwastiak et al., 2002).  This subgroup 
are also approximately 7.5 times more likely to die from suicide (Sadovnick et al., 1996).  
Regardless of whether depression is a reactive psychological problem or an ‘organic’ cause of 
MS (e.g., due to demyelination of key areas of the brain; Haussleiter et al., 2009), the adverse 
effects of untreated depression on MS disease course and daily functioning are undeniable 
(Fischer et al., 2015b; Kargiotis et al., 2010).  Indeed, depression is considered to be the most 
important determinant of treatment adherence, functional status, and quality of life (Siegert & 
Abernethy, 2005).  
Depression Assessment   
Depression remains underdiagnosed and undertreated in the MS population.  Rates of 
missed diagnoses are reported at approximately 30% and are likely attributable to the somatic 
and vegetative symptom overlap between the features of MS and psychiatric symptoms (e.g., 
altered sleeping patterns, appetite, fatigue, concentration), but also symptom denial and false 
reporting (Cetin et al., 2007; Feinstein et al., 2014; Fischer et al., 2015b; Skokou et al., 2012).  
Concerningly, up to 65% of adults with MS that meet the criteria for MDD, do not receive 
pharmacological or psychotherapeutic treatment (Mohr et al., 2006).   
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Ideally, the ‘gold standard’ clinician-administered interview should routinely be used 
in MS care to assess MDD.  However, self-report questionnaires have emerged as the 
predominant format for depression measurement in MS research due to their practicality and 
ease of administration (Feinstein et al., 2014).  Importantly, several depression measures have 
utility as a screening tool, with optimal cut-off scores for ‘caseness’ developed from receiver 
operating characteristic curve analysis (Habibzadeh et al., 2016).  Targeted measures, such as 
the Beck Depression Inventory and its variants (BDI; BDI-II; BDI-FS; Beck et al., 1961, 
1996, 2000) or the Center for Epidemiologic Studies Depression Scale (CES-D-10; Kohout et 
al., 1993), have also demonstrated good to excellent diagnostic validity for persons with MS; 
that is, the ability to correctly identify someone that meets clinical levels of depression 
(Amtmann et al., 2014; Benedict et al., 2003; Hind et al., 2016; Strober & Arnett, 2015; 
Watson et al., 2014).  Measures that incorporate depression subscales, such as the Hospital 
Anxiety and Depression Scales (HADS-D; Zigmond & Snaith, 1983), have also shown good 
content validity (i.e., correspondence between test items and depression symptoms) and test-
retest reliability (i.e., reliability over time; Waston et al., 2014).  In sum, available depression 
measures can reliably be used in applied and research settings as initial screening tools for 
mental health problems in MS (Hind et al., 2016).  
Depression Treatment   
In addition to accurate depression assessment for persons with MS, timely treatment 
is essential to reduce symptom severity and to improve health behaviours, such as treatment 
adherence (Kalb et al., 2019; Skokou et al., 2012).  Despite case control clinical trials 
demonstrating the benefits of pharmacotherapy (i.e., fluoxetine, sertraline; Feinstein et al., 
2014; Koch et al., 2011), a link between cognitive dysfunction—a pervasive MS symptom—
and poor treatment response to antidepressants has been shown (Julian & Mohr, 2006).  
Similarly, whilst psychotherapies (e.g., cognitive behaviour therapy) have demonstrated 
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robust, immediate benefits to mood (Feinstein et al., 2014; Hind et al., 2010), such therapies 
need to be carefully adapted to accommodate for the attention and information processing 
problems typically experienced by persons with MS (Choobforoushzadel et al., 2015; Solaro 
et al., 2018).  
Exercise Training and Depression in MS 
Exercise training offers a low-cost and accessible lifestyle treatment for depression in 
MS.  Among the general population, exercise is considered a good complement to both 
pharmacological and non-pharmacological treatments for depression (e.g., Craft, & Perna, 
2004).  Defined as “a type of physical activity consisting of planned, structured, and 
repetitive bodily movement,” exercise can help to improve and maintain physical fitness, 
including the ability to perform skill-related (e.g., agility, balance, coordination) or health-
related activity (e.g., endurance, strength, flexibility; American College of Sports Medicine, 
2014, pp. 2).  The exercise rehabilitation literature also makes a distinction between aerobic 
and nonaerobic exercise.  The former involves an increased and sustained heartrate to 
develop cardiorespiratory fitness (e.g., walking, running, cycling, swimming, rowing).  In 
comparison, nonaerobic exercise typically refers to muscular fitness, flexibility, and 
neuromotor exercise such as resistance training, yoga, and Pilates (Doyne et al., 1987; Hsu et 
al., 2019; Stanton & Reaburn, 2014).   
There are well-documented recommendations for exercise participation and exercise 
safety among persons with MS (Motl, 2014; Petajan & White, 1999; Pilutti et al., 2014).  
These guidelines specify that two weekly supervised sessions of moderate intensity aerobic 
activity (of ≥ 30 minutes) in addition to strength training of two major muscle groups, is 
required in order to improve aerobic capacity, muscle strength, and general fitness (Latimer-
Cheung et al., 2013).  Importantly, systematic reviews have highlighted regular exercise 
training as a potential solution for not only maximising patient activities and general 
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functioning, but also reducing disease relapse rate in comparison to no-treatment controls 
(4.6% for exercise vs. 6.3% for controls; Motl, 2014; Petajan & White, 1999).   
Several randomised controlled trials (RCTs) have examined the effect of exercise 
training on MS-related depression.  Notably, studies have typically examined aerobic 
endurance exercise as an ‘add-on’ therapy during inpatient MS rehabilitation (e.g., Dettmers 
et al., 2009).  Meta-analytic evidence certainly supports the benefit of exercise on depressed 
mood and affect when delivered as part of a broader multidisciplinary intervention for 
chronic disability groups (g = .45, 95% CI [.12, .79], p = .01; Dauwan et al., 2019).  The 
ability to draw conclusions on the reductive effects of exercise based on these findings are, 
however, limited given their consideration of exercise as a supplement to other evidence-
based components (e.g., physiotherapy, occupational therapy, nursing; Dauwan et al., 2019)     
The differential effects of unsupervised versus supervised exercise training also needs 
to be considered.  MS studies examining the efficacy of self-managed exercise programs have 
typically reported little or no improvement in depression symptom severity ratings (e.g., Paul 
et al., 2014; Romberg et al., 2005).  Unsupervised interventions are not only inconsistent with 
current exercise guidelines for persons with MS (Latimer-Cheung et al., 2013), but may result 
in a participant being less inclined to initiate or complete sessions due to the self-motivation 
required to exercise independently.  Motivation can further be impaired in individuals with 
depression.  This may explain the non-significant treatment effects experienced by Romberg 
and colleagues’ (2005) exercise group, many of whom exceeded the clinical cut-off score of 
15 on the CES-D-10 at baseline (Björgvinsson et al., 2013).  Those who are depressed may 
find it difficult to exercise without the benefits of social exposure and monitoring that an 
intervention supervised by a qualified health professional affords (Petajan et al., 1996).  In 
saying this, there is also evidence that baseline depression severity does not moderate 
capacity for treatment change in MS samples (Dalgas et al., 2015; Herring et al., 2017). 
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The selection of control group is a further consideration.  Immediate within-group 
reductions in depression symptoms have been associated with exercise training; although, 
improvements in mood have also been reported for participants in an active control condition 
who received training in abdominal breathing and contraction-relaxation (Grazioli et al., 
2019).  Similar treatment effects have also been noted when comparing exercise training with 
yoga or sports climbing (Siengsukon et al., 2016), or even low intensity walking and 
stretching (Velikonja et al., 2010).  Any treatment effects associated with exercise are best 
examined by using a non-exercise control – in order to highlight the magnitude of any 
improvements in depression severity associated with exercise, specifically (Temple & 
Ellenber, 2000). 
The type of exercise examined may also contribute to the mixed findings in the MS 
literature.  For example, aerobic exercise has been shown to be highly effective at reducing 
depression severity (Béland et al., 2020; Morres et al., 2019).  The argument is that 
maintaining an increased rate of cardiovascular activity for sustained periods, such as during 
running, is associated with increased production of endorphin hormones which promote 
feelings of wellbeing and reduced pain perception.  This phenomenon, referred to as 
‘runner’s high’ in the literature (Hicks et al., 2019), is applicable to other forms of aerobic 
exercise that allow a similar sustained cardiovascular state (e.g., swimming, cycling; 
Amorosi, 2014; Antunes et al., 2016; Raichlen et al., 2012).  Emerging evidence also 
suggests that general exercise training may promote mood by facilitating psychological 
improvements in self-esteem and self-efficacy (i.e., belief to achieve a task; Haller et al., 
2018; Legrand, 2014; Pickett et al., 2012).  Less strenuous forms of nonaerobic exercise, such 
as yoga may, therefore, not only improve depression due to exercise-mediated psychological 
improvements, but also appeal more to those experiencing low energy due to a combination 
of their MS and depression symptoms (Martinsen et al., 1989).  To date, however, MS 
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research has not been able to confirm the particular type of exercise training that is most 
effective for depression (Ensari et al., 2014).   
Exercise volume, characterised by the total number of sessions over the course of a 
treatment, is an additional feature that may influence treatment efficacy.  Meta-regressions 
have identified exercise volume as a significant (p < .01) moderator of MS-related 
depression: three or more sessions of exercise per week have produced large effects (g = .81, 
95% CI [.43, 1.20]) compared with the benefits reported by participants who exercised less 
than twice a week (g = .36, 95% CI [.13, .59]; Herring et al., 2017).  Although these results 
indicate an exercise dose-response effect, they are not consistently supported by other MS 
studies (Dalgas et al., 2015; Ensari et al., 2014).  Studies with healthy adults have also been 
unable to confirm whether a higher session volume has a larger effect on depression symptom 
severity than sessions that are scheduled on a less frequent basis or smaller volume (Brown et 
al., 2012; Hamer et al., 2009; Nebiker et al., 2018).   
Current Study 
Exercise training may help to promote mental health among adults living with MS, by 
reducing depression symptom severity.  However, the efficacy of exercise training remains 
unclear, with prior reviews in this area including studies using multidisciplinary programs, 
unsupervised interventions, and/or active controls - all methodological features that limit the 
ability to draw conclusions on the isolated effect of exercise (Dalgas et al., 2015; Ensari et al., 
2014; Herring et al., 2017).  There also remains a need to define the most optimal type and 
dose of exercise.  The current study systematically reviews the exercise and MS literature, 
using meta-analytic techniques to consolidate the available data and help to identify the 
features and qualities of exercise studies that may impact on treatment effectiveness.  A meta-
analysis is considered the ‘gold-standard’ of evidence-based healthcare as it increases the 
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sample size, statistical power, and accuracy of effect size estimates when compared to a 
single study (Borenstein et al., 2009).  The specific aims of this meta-analysis are to:  
1. Integrate and analyse quantitative evidence regarding the effectiveness of exercise 
training, in comparison to waitlist, standard care, or attention controls.   
2. Explore potential sources of heterogeneity among included studies, namely the 
type of exercise training (aerobic vs. nonaerobic), exercise volume (total number 
of sessions over the course of treatment), and baseline depression scores. 
3. Evaluate the strength of evidence through a critical appraisal of the reporting 









Literature Search  
Five electronic databases (Cochrane Library, Embase, PEDro, PsycINFO, PubMed) 
were searched from database inception to March 11 2020, with automatic email search alerts 
enabled up until June 1 2020.  Studies examining the effect of exercise interventions in 
persons with MS were identified using two broad search categories relating to: 1) the 
population of interest - “multiple sclerosis”, and 2) the method of intervention - “exercise”.  A 
comprehensive list of index terms, using relevant synonyms for each search category, was 
developed in consultation with an expert research librarian.  Search terms were customised to 
the vocabulary of each database (i.e., Emtree – Embase, Thesaurus – PsycINFO, MeSH – 
Pubmed), and combined using truncation and wildcard operators (for full logic grids, see 
Appendix A).  Terms were deliberately kept broad to ensure that all possible studies were 
identified.  The reference lists of included studies and relevant reviews (reviews by: Dauwan 
et al., 2019; Dalgas et al., 2015; Ensari et al., 2014; Herring et al., 2017) were additionally 
screened to identify any further studies that may have been missed, with one additional study 
identified through this process.   
Study Eligibility and Screening 
In addition to being peer-reviewed articles published in the English language, or with 
English translation, studies were screened using Population Intervention Comparison 
Outcome Design (PICO-D) criteria.  These criteria helped to facilitate the identification and 
categorisation of information specific to this review (Agoritsas et al., 2012).   
Population 
Studies involving adult participants (defined as ≥ 18 years) with a self-reported or 
physician-confirmed MS diagnosis (i.e., as determined by McDonald or Poser Criteria, MRI, 
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laboratorial data, medical history; McDonald et al., 2001; Poser et al., 1983; Thompson et al., 
2018).  There was no restriction on disease severity, with both relapsing and progressive 
forms included.  Studies that examined samples with various neurological or physical 
disabilities but did not report, or have available, the data for their MS sample, were excluded.  
Intervention 
All studies examined an exercise training intervention in accordance with the 
American College of Sports Medicine’s (2014) definition of exercise: that is, a planned, 
structured, repetitive, and purposeful regime to maintain or improve physical fitness.  Studies 
involving single bouts of exercise, or physical activity without a focus on improving fitness 
specifically, were excluded.  Aerobic exercise, which typically involves low to highly 
strenuous cardiovascular exercise over a continuous and extended period (e.g., walking, 
running, cycling, aquatics, circuit-style training), as well as nonaerobic exercise, or short 
bouts of intense exercise efforts (e.g., strength and resistance training, yoga, Pilates), were 
eligible.  The use of standard gymnasium equipment (e.g., jump ropes, treadmills, 
ergometers, resistance bands, weight training machines) was also acceptable, although the 
intervention had to involve some form of face-to-face supervised practice provided by a 
trained health professional (e.g., exercise physiologist, physiotherapist; Latimer-Cheung et 
al., 2013; Schuch et al., 2016).  Exercise interventions that were self-managed, delivered as 
part of a multidisciplinary rehabilitation program, or involved the use of specialised 
equipment and techniques (e.g., functional electrical stimulation, vibration machines, 
transcranial stimulation, neuromodulation, robot assistance), were excluded.   
Comparison 
To determine whether any observed effect arose directly from the exercise 
intervention, only studies that used a non-exercise, passive control condition (e.g., waitlist, 
standard medical, psychosocial monitoring) were eligible (Gharakhanlou et al., 2020).   




Established self-reported or clinician-administered measures specifically designed to 
screen for depression symptom severity (e.g., BDI, CES-D-10) or disorder (e.g., MDD) were 
included.  Depression subscales were also eligible, provided that psychometric data (for the 
MS or the general population) were available (see Appendix B for a list of eligible measures).  
Measures of general affect or distress, or psychological measures that had been purposely 
designed for a study, were excluded. 
Design 
Studies had to randomly allocate participants with MS to an exercise intervention or 
control group: a design that is considered the ‘gold standard’ for evaluating treatment 
effectiveness (Hariton & Locascio, 2018).  Studies also had to use a repeated measures 
design, whereby group depression scores were reported pre and post-intervention.   
Study screening was undertaken by the student researcher (X.X.) using Covidence 
systematic review software (Veritas Health Innovation).  Duplicates were first removed and 
then titles and abstracts of potentially eligible records screened.  The full-texts of relevant 
studies were then accessed and re-screened against the eligibility criteria.  To ensure 
reliability of the screening process, a second researcher (project supervisor, X.X.) 
independently assessed 113 records.  Inter-rater reliability was high (Viera & Garrett, 2005), 
with reviewers agreeing in 97% of cases (𝑘 = .89).  The few discrepant articles were resolved 
through consensus discussion.  
Data Extraction, Organisation and Preparation 
Corresponding with the Preferred Reporting Items for Systematic Reviews and Meta-
Analysis (PRISMA) guidelines (see Appendix C; Moher et al., 2009), a purposely designed 
data extraction sheet was used to organise and collate data for each study (see Appendix D). 
Extracted data included:  
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a. Study characteristics: Sample size; country; depression measure; control condition; 
and rate of attrition or dropout from the primary (exercise) intervention.  Exercise 
intervention details were extracted in accordance with the Template for Intervention 
Description and Replication Checklist (TIDier; Hoffmann et al., 2014; see also 
http://www.tidierguide.org/) to ensure sufficient description of both the exercise and 
control conditions examined.  This included detail relating to the type of exercise 
(aerobic or nonaerobic exercise) and, where available, number of sessions (per week), 
session duration (in minutes), and treatment duration (in weeks).   
b. Key sample parameters: Mean age (SD) and male:female ratio.  
c. MS-specific information: Disease subtype (relapsing-remitting, or progressive forms); 
mean (SD) disease duration (in years) and level of physical disability or function (as 
defined by the Expanded Disability Status Scale [EDSS]; Kurtzke, 1983).  
d. Effect size data: Group means and SDs for each depression measure, pre and post-
intervention were extracted from each study.  Where these data were unavailable, data 
that could be converted to standardised mean differences (Hedges’ g) were obtained.  
The data for two studies required conversion prior to analysis.  Negaresh and 
colleagues (2019) categorised participants as ‘normal weight’ and ‘overweight.’  
Here, the means and SDs were averaged to provide an overall score for the 
intervention and control groups.  Dalgas (2010) reported 95% confidence intervals 
(CI) for their depression scores, which were converted to SDs (Higgins et al., 2019).  
Risk of Bias Assessment 
The methodological quality of each study was evaluated using the Physiotherapy 
Evidence Database (PEDro) Scale: a tool based on the Delphi Checklist for physical therapy 
interventions (see Appendix E for criteria; Maher et al., 2003; see also Verhagen et al., 1998).  
Each study was rated against 11 pre-specified criteria relating to measurement, analyses, 
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reporting transparency (e.g., specifying eligibility criteria), study design (e.g., randomisation, 
blinding, allocation concealment), and sample characteristics (e.g., comparability of groups at 
baseline).  A score of 1 (criterion met) or 0 (criterion not met) was assigned for each criterion, 
and each study.  Given that not all items equally contribute to a total score for the PEDro 
Scale (i.e., item relating to eligibility criteria is not scored), a component analysis approach 
was adopted, whereby only individual items were considered (da Costa et al., 2012).  To 
ensure reliability of the quality assessment, ratings were compared to confirmed scores for 
each study available on the PEDro database (http://www.pedro.org.au).  Inter-rater reliability 
was high, with 98% accuracy for independent ratings (Viera & Garrett, 2005).  
Effect Size Calculations 
Effect size data were entered into Comprehensive Meta-Analysis software (CMA  
Version 3.3.070, November 2014; Borenstein et al., 2013).  The effect size estimate selected 
for this meta-analysis was Hedges’ g, which corrects for bias in small samples (Lakens, 
2013).  The formula for g involves subtracting the mean (post-pre) change in the control 
group from the mean change in the intervention group, and then dividing this figure by the 
pooled and weighted SD for each group (Elllis, 2010).  A random-effects model was used for 
all calculations to account for the range of exercise interventions, clinical heterogeneity of 
MS, and different depression measures used (Borenstein et al., 2009; Cumming, 2012).   
Effect size g was computed for each depression measure and study.  Where a study 
contributed more than one effect estimate (e.g., multiple depression measures or 
interventions), individual g’s were averaged prior to being pooled in a given meta-analysis to 
ensure no issues of data dependency arose (Cohen, 1988).  A pre-post correlation of .70, 
considered a conservative value for studies with a repeated measures design, was imputed 
into CMA in order to calculate g (Estrada et al., 2019).  Individual g’s were then weighted by 
their study’s inverse variance to account for increased sampling error and variability from 
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smaller samples (gw; Lipsey & Wilson, 2001).  Effect sizes were interpreted using Cohen’s 
(1988) conventions for the social sciences, with values of .20, .50, and .80 corresponding to 
small, medium, and large effects.  The direction of g was also standardised so that a positive 
value indicated greater improvement (i.e., lower depression scores) with exercise training.  In 
addition, p values were used to infer statistical significance of individual and pooled g’s and 
95% CIs computed to estimate the precision of each g/gw.  Narrower CIs indicate higher 
precision (Higgins et al., 2019), whilst CIs which contain the value of zero represent a non-
significant estimate (Cumming, 2012).   
Between-study heterogeneity was identified and quantified using tau (), and I2 
statistics.  Tau () represents the SD for the overall gw, or degree of dispersion about the mean 
effects.  The I2 statistic quantifies the total variability across effect estimates as a percentage, 
whereby values of 25%, 50%, and 100%, indicate low, medium, and substantial 
heterogeneity, accordingly (Higgins et al., 2003).   
Publication bias, also referred to as the ‘file drawer’ problem, is a key concern in 
meta-analyses that rely on published data, as studies with significant and large effects are 
more likely to be published (Borenstein et al., 2009).  In the current meta-analysis, this bias 
was assessed with several statistics.  First, a funnel plot analysis was conducted to detect 
potential publication bias across all included studies, followed by the trim-and-fill method.  
In a funnel plot, intervention effect estimates from individual studies are plotted against each 
study’s standard error.  In the absence of publication bias, a funnel plot should be 
symmetrical: with larger N studies scattered narrowly towards the top of the plot and effect 
sizes from smaller studies scattered widely at the bottom (Sterne et al., 2011).  This result is 
statistically confirmed by the trim-and-fill method, a non-parametric test which identifies 
how many hypothetical studies would need to exist to correct for asymmetry in a funnel plot 
(Sterne et al., 2011).  Orwin’s fail-safe N (Nfs; Orwin, 1983) was calculated for each 
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subsequent meta-analysis.  Nfs represents the hypothetical number of studies needed to 
‘nullify’ the effects of g to a small, meaningless size (i.e., g = .20; Orwin, 1983).  An Nfs 
value needed to exceed the total number of studies included in this meta-analysis in order to 
be considered robust. 
Sensitivity and Moderator Analyses 
Potential outlier effects were identified using a sensitivity analysis.  This involved re-
running the meta-analysis with all included studies and then removing one study at a time to 
see whether this changed the overall effect size magnitude or level of significance 
(Borenstein et al., 2009).  A subgroup analysis was then conducted to examine the potential 
impact of exercise type (i.e., aerobic vs. nonaerobic) on group differences.  This involved a 
Q-test based on analysis of variance (Qbetween), with significant results (i.e., p < .05) indicating 
meaningful subgroup differences (Borenstein et al., 2009).  Finally, there were sufficient data 
to undertake two univariate meta-regressions (Nstudies > 10 per independent variable; Higgins 
et al., 2019) to examine the association between exercise volume (total number of sessions 
over the course of an exercise program) and baseline depression scores (the average was 
taken for studies administering multiple interventions) on effect size estimates.  This analysis 
involved a random effects model with inverse variance weighting of effect sizes.  Both Q 
model (Qmodel) statistics, which show variability associated with the regression model, and Q 
residual (Qresid) statistics, which indicate variability unaccounted for by the model, were 












Electronic database searches yielded 10,808 records, of which 6373 potentially 
relevant titles and abstracts were screened (see Figure 1).  A further 113 records were retained 
for full-text review.  Fifteen authors were contacted for additional data, with five responding 
(Learmonth, 2012; Learmonth et al., 2011; Negaresh et al., 2019; Oken et al., 2004; 
Sutherland et al., 2001; Tollár et al., 2020).  During the screening process, two papers with 
overlapping samples were identified (Bahmani et al., 2019, 2020): only the study with 
complete pre post-intervention depression data was retained (Bahmani et al., 2019).  The final 
sample comprised of 15 independent RCTs.   
Sample Characteristics 
 The pooled sample of 544 persons with MS (Exercise = 313; Control = 231) were 
primarily middle-aged (mean age range = 31.12–54.60; see Table 1).  Both groups had been 
living with chronic (i.e., > 9 years) relapsing (74%) or progressive forms of MS (26%) and 
mild to moderate levels of disability (i.e., Expanded Disability Status Scale < 5; Meyer-
Moock et al., 2014), although MS details were not routinely reported (Nstudies ≤ 10).  Most 
(83%) participants were female, consistent with the commonly reported 3:1 ratio of females 
to males diagnosed (see Appendix F; Ribbons et al., 2017).  In the 13 studies that used 
depression measures with reported cut-off scores, 49% of the pooled sample (i.e., 230 of 472 
participants) were classified as ‘depressed’ at baseline (see Appendix B for cut-off scores per 
measure). 
Study Characteristics 
Most studies originated in Europe (Nstudies = 6), followed by the Middle East  
 




PRISMA Flowchart of Study Selection Process (Moher et al., 2009) 
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Table 1  
Pooled Sample Characteristics  
 
Exercise  Control 
 
Nstudies Nparticipants M (SD) Median 
 
Nstudies Nparticipants M (SD) Median 
Sample size 15 313 20.1 (10.1) 15  15 231 15.4 (5.9) 15 
Age (in years) 15 313 44.1 (7.8) 47.4  15 231 43.8 (7.6) 45.5 
Disease duration (in years) 13 273 9.1 (3.4) 7.3  13 205 9.8 (4.8) 7.4 
Disability severity (EDSS) 10 257 3.9 (1.7) 3.7  10 174 3.7 (1.8) 3.2 
          
Gender                                             Female     12 212    12 153   
                                               Male      12 39    12 37   
MS sub-type                Relapsing-remitting 6 93    6 75   
                                    Progressive  6 34    6 26   
Note. Nstudies = number of studies providing this data; Nparticipants = number of participants providing this data; M = mean; SD = standard deviation; 
EDSS = Expanded Disability Status Scale. 
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(Nstudies = 5), North America (Nstudies = 3), and Australia (Nstudies = 1; see Table 2).  No 
individual study contributed more than 12% of the pooled sample size.  Sample sizes were 
typically small, representing pilot or feasibility studies (Nrange = 9–61).   
Depression symptom severity was measured with 10 individual self-assessment tools, 
more commonly the BDI (Nstudies = 5), followed equally by the Profile of Mood States – 
Depression Subscale (POMS-D; Nstudies = 3; McNair et al., 1971), and the HADS-D (Nstudies = 
3).  Measures that align with diagnostic symptom criteria (i.e., Diagnostic and Statistical 
Manual of Mental Disorders – Fifth edition; DSM-V; American Psychiatric Association, 
2013), and considered to be sensitive to treatment change, were also used: the 30-item 
Inventory of Depressive Disorders (IDS-SR30; Rush et al, 2000) and 16-item Quick Inventory 
of Depressive Symptomology (QIDS-SR16; Rush et al., 2003).  
Intervention Characteristics 
Twenty different exercise interventions were evaluated across the 15 studies.  Most 
involved aerobic (Nstudies = 8), then nonaerobic (Nstudies = 3) interventions.  Four studies 
delivered multiple respective interventions of either, or both types of exercise.  A single study 
examined three separate aerobic interventions: upper body arm, rowing, and bicycle 
ergometry (Briken et al., 2014).  Other common aerobic interventions included treadmill 
training (walking/jogging), circuit training, and aquatics.  Nonaerobic exercise involved 
yoga, Pilates, or resistance training. 
Exercise sessions were typically delivered in a group setting (Nstudies = 14) and 
supervised by various disciplines including certified instructors, neurologists, physical 
therapists, physiotherapists, or physiatrists - who also provided technique advice.  Exercise 
programs were catered to a group of individuals with predominantly sedentary activity levels.  
In particular, six studies required participants to have refrained from exercise for periods 
ranging from 4 to 52-weeks prior to commencement of the study, while three studies
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Table 2  
Study and Exercise Intervention Characteristics 
Lead author (date) Country 

















10 1) Aerobic  
2) Nonaerobic 
1) Treadmill exercise 
2) Yoga 
3 60-70 8 - 
- 
Waitlist 
Bahmani (2019) Iran 47 
[0:47] 
26 21 Aerobic Endurance treadmill & bicycle 
ergometry 
3 30-45 8 19.2% Attention 





10 Aerobic 1) Upper body arm ergometry  
2) Rowing ergometry  
3) Bicycle ergometry  




Çakit (2010) Turkey 30 
[-] 
15 15 Aerobic Progressive resistance bicycle 
ergometry & balance exercise  
2 68-85 8 6.7% Standard care 
Dalgas (2010) Denmark 31 
[-] 
15 16 Nonaerobic Progressive resistance training  2 - 12 15.8% Standard care 
Fleming (2019)  Ireland 9 
[0:9] 
3 6 Nonaerobic Pilates  2 60 8 40% Waitlist 
Hebert (2011) US 26 
[4:22] 
13 13 Aerobic Endurance bicycle ergometry & 
stretching 
2 55 6 0% Waitlist 
Learmonth (2011) Scotland 32 
[9:23] 
20 12 Aerobic Endurance circuit training  2 45-60 12 25% Standard care 
Miller (2011) Scotland 30 
[11:19] 
15 15 Nonaerobic Physiotherapy strength & flexibility 
training 
2 60 8 0% Standard care 
Negaresh (2019) Iran 61 
[21:40] 
34 27 Aerobic Interval bicycle ergometry  3 42-66 8 5.6% Standard care 




20 1) Aerobic 
2) Nonaerobic 
1) Bicycle ergometry  
2) Yoga  
1 - 
90 
26 1) 28.6% 
2) 15.4% 
Waitlist 
Petajan (1996)  US 46 
[15:31] 
21 25 Aerobic Arm and leg ergometry  3 40 15 - Standard care 




18 1) Aerobic 
2) Nonaerobic  
1) Aquatic training  
2) Yoga  
3 60 8 - 
- 
Attention 
Sutherland (2001) Australia 22 
[10:12] 
11 11 Aerobic Aquatic training & land-based 
training 
3 45 10 - Standard care 
Tollár (2020) Hungary 26 
[2:24] 
14 12 Aerobic High-intensity bicycle ergometry  5 60 5 0% Waitlist 
Note. a number of participants allocated to groups at baseline; M = male; F = female; EX = exercise intervention; C = control group; b  number who did not complete EX; (-) = data not provided. 
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excluded participants with recent (3–6 months) experience in the particular exercise method 
used.  Sessions mostly occurred twice or thrice weekly over a period of 5 to 26-weeks (M = 
10.00, SD = 5.06), to build general strength or endurance.  Individual sessions ranged from 
15 to 90 minutes (M = 56.11 minutes, SD = 15.53).   
Exercise intensity was generally unreported, with only six studies formally evaluating 
this (e.g., Borg Rating of Perceived Exertion [RPE] Scale; Borg, 1998).  Studies did, 
however, target programs to participant differences in fitness levels - by measuring age-
predicted peak heartrate (using heart rate monitors), aerobic capacity (i.e., maximal oxygen 
uptake or milliliters of oxygen used in one minute per kilogram of body weight; Lundby et 
al., 2017), or maximum effort on a resistance movement (i.e., maximum amount of weight in 
kilograms that a person can lift for one repetition).  Four studies required self-regulation of 
exercise intensity, such as choosing when to increase the speed on a treadmill or how long to 
hold a yoga pose (Ahmadi et al., 2013; Fleming et al., 2019; Learmonth et al., 2011; Oken et 
al., 2004).  
 Dropout or attrition rates, where reported, were generally low (M = 13.5%, SD = 11.8; 
Nstudies = 11).  Three interventions retained all participants until completion, indicating high 
levels of engagement (Hebert et al., 2011; Miller et al., 2011; Tollar et al., 2020).  Conversely, 
Fleming (2019) reported that 40% of their intervention group did not complete the allocated 
Pilates intervention.  However, the sample size for the intervention condition was small (N = 
5) and the reasons for withdrawal were unrelated to the exercise intervention (e.g., side 
effects from a medication, injury obtained at work).  Importantly, no adverse events or 
injuries due to exercise training were reported across all studies. 
 Most studies used standard care controls, by maintaining usual treatments aside from 
any exercise training (Nstudies = 7).  Waitlist controls, whereby exercise treatment was offered 
upon study completion, were also common (Nstudies = 6).  Two studies used an attention 
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control condition, which involved participants meeting with hospital or research personnel 
for the same frequency and duration as the exercise group and, thereby, controlling for 
potential confounding effects of social exposure from exercise training (Bahmani et al., 2019; 
Razazian et al., 2015). 
Risk of Bias Assessment 
The proportion of studies meeting each criterion of the PEDro Scale is presented in 
Figure 2 (see Appendix G for individual study ratings).  Eligibility criteria were explicitly 
stated (Criterion 1: 100% fulfilled) and, as per the requirements of this review, all participants 
were randomly allocated to their groups (Criterion 2: 100% fulfilled).  Allocation was, 
however, only concealed in some studies (e.g., use of sealed opaque envelopes; Criterion 3: 
60% fulfilled).  Randomisation methods were, however, effective – as suggested by the 
comparability of the exercise and control groups on key sample characteristics (i.e., baseline 
depression scores, MS duration and severity; Criterion 4: 100% fulfilled).  Given the physical 
nature of the intervention under examination, blinding (of subject and therapist) was an issue 
across all studies (Criteria 5-6: 0% fulfilled).  Assessor blinding was also difficult to achieve 
(Criterion 7: 53% fulfilled).  Attrition was minimal, with at least 85% of participants 
completing both pre and post-intervention assessments (Criterion 8: 60% fulfilled).  
However, intent-to-treat analysis (i.e., where all participants are included in the analysis 
according to original group assignment, regardless of whether the treatment was received, 
completed, or not; McCoy, 2017) was not common, despite being a recommended statistical 
method for RCTs (Criterion 9: 33% fulfilled).  Between-group statistical comparisons (e.g., 
one-way ANOVA, p-values; Criterion 10: 93% fulfilled) and measures of variance (e.g., SDs, 
95% CIs; Criterion 11: 93% fulfilled) were reported.  In sum, most studies (Nstudies = 11) 
provided sufficient methodological detail consistent with level one evidence (Burns et al., 
2011; Maher et al., 2003). 




Proportion of Included Studies Meeting Each Criterion on the PEDro Scale (Maher et al., 2003) 
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Effectiveness of Exercise 
Short-Term Effects 
Across all 15 studies, the pooled and weighted g was large and significant: exercise 
training was associated with large and immediate reductions in depression symptom severity 
scores compared to peers who accessed standard care, psychosocial monitoring, or were 
waitlisted (Table 3).  This finding was, however, susceptible to publication bias.  As seen in 
Figure 3, a funnel plot analysis indicated an underestimation of effect with an additional four 
studies ‘filled’ due to lack of symmetrical dispersion within the plot (Duval & Tweedle, 
2000).  These results were also characterised by substantial between-study heterogeneity, 
with small to very large effects represented (I2 = 81.46,  = .70).  This included statistically 
significant group differences (p < .01) in favour of exercise reported by seven studies, but 
also small to large imprecise effects (i.e., wide CIs) as found in eight studies.   
 
Figure 3 
Funnel Plot of Standard Error by Hedges’ g 
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Table 3  
Standardised Mean Group Differences (Hedges’ g) by Study With Forest Plot 
Lead author (date) N g/gw 
95% CI 
  p Forest plot of g 
+ 95% CI 
Weight 
(random) LL UL 
Razazian (2015) 54 2.73 2.09 3.36 .00  6.93 
Petajan (1996) 46 2.57 1.79 3.35 .00 6.37 
Briken (2014) 42 1.00 .48 1.52 .00 7.37 
Bahmani (2019) 47 .81 .22 1.40 .01 7.11 
Dalgas (2010) 31 .79 .08 1.51 .03 6.62 
Ahmadi (2013) 31 .71 .11 1.32 .02 7.03 
Fleming (2019) 9 .68 -.62 1.99 .31 4.40 
Sutherland (2001) 22 .66 -.17 1.48 .12 6.17 
Negaresh (2019) 61 .64 .13 1.15 .02 7.39 
Learmonth (2011) 32 .42 -.29 1.12 .25 6.65 
Çakit (2010) 30 .29 -.41 .99 .42 6.67 
Tollár (2020) 26 .24 -.51 .99 .53 6.48 
Oken (2004) 57 .20 -.25 .64 .38 7.63 
Miller (2011) 30 .10 -.60 .80 .78 6.69 
Hebert (2011) 26 .09 -.65 .84 .81 6.49 
Total 544 .79 .39 1.19 .00  
 
Note. N = total sample size; g = Hedges’ g; Hedges’ gw = weighted Hedges’ g 
(note: weighting only applies when ≥ 2 studies are combined); CI = 95% 
confidence interval (with lower and upper limits); p = significance level. 
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Further examination of individual study results, grouped by outcome, identified large 
and positive effects associated with both aerobic and nonaerobic programs (Table 4).  These 
findings were based on mood subscales (POMS-D) but also targeted measures of depression 
(BDI, BDI-FS, IDS-SR30).  The large Nfs values indicate that these findings are robust.  Four 
studies in particular reported large (g > .80) to very large (g ≥ 1.00) highly significant overall 
effects.  This included large individual effects associated with nonaerobic yoga (Razazian et 
al., 2015), as well as endurance aerobic exercise such as aquatic or rowing, cycling, and arm 
ergometry training (Bahmani et al., 2019; Briken et al., 2014; Petajan et al., 1996; Razazian 
et al., 2015).  Interestingly, Fleming and colleagues (2019) also identified a very large and 
significant individual effect using the POMS-D scale; although, negligible (QIDS-SR16) and 
small (HADS-D) non-significant effects were also found in this study.  Moreover, medium 
effects were reported by studies that examined intermittent styles of training, whereby active 
and comparative rest periods were incorporated.  For example, resistance training with rests 
between weightlifting efforts (Dalgas et al., 2010) and cycling intervals (Negaresh et al., 
2019).  A further five studies reported small effects (grange = .04–.29) with wide 95% CIs.  
The moderate and positive overall effects reported by Ahmadi et al. (2013), Fleming et al. 
(2019), and Sutherland et al. (2001) were non-significant, likely due to their small Ns (N < 
32).  The mixed findings are further highlighted by the heterogeneity statistics. 
Longer-Term Effects 
Four studies examined the longer-term impact of exercise, from 4 to 52 weeks post-
intervention (see Table 5).  The weighted g was negligible, negative, and not statistically 
significant.  Given the small number of studies contributing to these data, no firm conclusions 
about the longer-term effects of exercise can be drawn.  Interestingly, Learmonth and 
colleagues (2011) identified a reverse effect at 26-weeks following their aerobic-based  




Table 4  
Short-Term (Baseline to Post-Intervention) Effects Associated With Exercise Training  
 


















Lower Upper I2  
Petajan (1996) Aerobic POMS-D  1 46  2.57 1.80 3.35 .00    
Fleming (2019) Nonaerobic   1 9  1.59 .16 2.03 .03    
Oken (2004) Aerobic   1 57  .31 -.35 .96 .36    
 Nonaerobic      .04 -.56 .63 .90    
   Total POMS-D 3 112 1.41  -.35 3.17 .12 18 93.18 1.48 
Briken (2014) Aerobic IDS-SR30  1 42  1.00 0.48 1.52 .00    
Razazian (2015) Nonaerobic BDI  1 54  2.83 1.91 3.74 .00    
 Aerobic      2.63 1.75 3.51 .00    
Ahmadi (2013) Nonaerobic   1 31  .78 -.07 1.64 .07    
 Aerobic      .65 -.22 1.47 .14    
Negaresh (2019) Aerobic   1 61  .64 .13 1.15 .02    
Çakit (2010) Aerobic   1 30  .29 -.41 .99 .42    
Tollár (2020) Aerobic   1 26  .24 -.51 .99 .53    
   Total BDI 5 202 .93  .045 1.81 .04 18 89.74 .95 
Bahmani (2019) Aerobic BDI-FS  1 47  .81 .22 1.40 .01    
Dalgas (2010) Nonaerobic MDI  1 31  .79 .08 1.51 .03    
Sutherland (2001) Aerobic POMS-SF-D  1 22  .66 -.17 1.48 .12    
Learmonth (2012) Aerobic HADS-D  1 32  .42 -.29 1.12 .25    
Fleming (2019) Nonaerobic   1 9  .41 -.83 1.66 .52    
Miller (2011) Nonaerobic   1 30  .10 -.60 .80 .78    
   Total HADS-D 3 71 .28  -.18 .74 .24 1 .00 .00 
Oken (2004) Nonaerobic CES-D-10  1 57  .37 -.23 .97 .22    
 Aerobic      .07 -.59 .72 .84    
Hebert (2011) Aerobic BDI-II  1 26  .09 -.65 .84 .81    
Fleming (2019) Nonaerobic QIDS-SR16  1 9  .05 -1.18 1.28 .94    
Note. Nstudies = number of studies providing this data; Nparticipants = number of participants providing this data; Hedges’ gw = weighted standardised mean difference (note: weighting only applies 
when ≥ 2 studies are combined); p = significance level; CI = 95% confidence interval for g/gw; Nfs = fail-safe N statistic;  (Tau) = estimate of variance; I2 = proportional estimate of true effect 
variance over sampling error observed; Measures: POMS-D = Profile of Mood States – Depression Subscale; IDS-SR30 = Self-Report Quick Inventory of Depression Symptomology; BDI = 
Beck Depression Inventory; BDI-FS = Beck Depression Inventory – Fast Screen for Medical Patients; MDI = Major Depression Inventory; POMS-SF-D = Profile of Mood States Short Form 
– Depression Subscale; HADS-D = Hospital Anxiety and Depression Scale – Depression Subscale; CES-D-10 = Centre for Epidemiologic Studies Depression Scale – Boston (Short form); 
BDI-II = Beck Depression Inventory – Second Edition; QIDS- SR16 = Quick Inventory of Depressive Symptomology. 
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Table 5  
Longer-Term (Post-Intervention to Follow-Up) Effects Associated With Exercise Training 
 




















Lower Upper I2   
Hebert (2011) Aerobic BDI-II 4 1 26  .28 -.47 1.03 .46 
   
               
Miller (2011) Nonaerobic HADS-D 8 1 28  -.03 -.75 .69 .93    
               
Dalgas (2010) Nonaerobic MDI 12 1 31  -.36 -1.05 .33 .31    
               
Learmonth (2011) Aerobic HADS-D 26 1 32  -1.06 -1.80 -.32 .01    
  52 1 32  .25 -.45 .95 .48    
               
  Total   4 117 -.18  -.50 .14 .28 0 .00 .00 
Note. Nstudies = number of studies providing this data; Nparticipants = number of participants providing this data; Hedges’ gw = weighted standardised mean difference (note: weighting only 
applies when ≥ 2 studies are combined); p = significance level; CI = 95% confidence interval for g/gw; Nfs = fail-safe N statistic;  (Tau) = standard deviation of gw; I2 = proportional 
estimate of true effect variance over sampling error observed. 
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intervention: depression severity scores worsened for exercise participants, whereas controls 
reported an improvement in mood.  However, at 52-weeks, these group differences were no 
longer significant (Learmonth et al., 2011). 
Sensitivity and Subgroup Analyses 
Sensitivity analyses revealed there were no outliers: the overall effect remained large 
and statistically significant even after removing individual studies.  Moreover, the 
contribution of exercise type to study heterogeneity was examined by comparing aerobic 
(Nstudies = 8) to nonaerobic interventions (Nstudies = 3).  To ensure data independence, the four 
studies delivering multiple exercise interventions with the same control group were excluded 
from this analysis (Ahmadi et al., 2013; Briken et al., 2014; Razazian et al., 2015; Oken et al., 
2004).  Aerobic interventions were associated with large and significant group differences  
(gw = .71, 95% CI [.25, 1.17], p < .01); although, these findings were characterised by 
significant between-study heterogeneity (I2 = 75.44,  = 61).  In comparison, nonaerobic 
interventions consistently produced non-significant effects (gw = .50, 95% CI [-.31, 1.31], p 
= .23, I2 = 0,  = 0).  However, differences between the two subgroups were not statistically 
significant (Qbetween (1) = .19, p = .67). 
Meta-Regressions 
The contribution of exercise volume and baseline depression scores to heterogeneity 
were explored with two univariate meta-regressions (see Table 6 and Appendix H for 
regression scatterplots).  Both variables emerged as significant moderators of depression 
severity, with Qmodel statistics indicating that each explained 31% and 37% of the inter-study 
variance in the pooled effect of exercise, respectively.  That is, higher volumes of exercise 
were associated with greater reductions in depression severity scores.  Participants who self-
reported more severe symptoms of depression at baseline also demonstrated larger resulting 
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improvements after exercise programs.  However, results of the Qresid statistic for each 
regression indicated that some unexplained heterogeneity in the pooled effect size remained. 
 
Table 6  
Univariate Meta-Regressions Examining the Impact of Covariates on Pre to Post-







Test of model Goodness of fit 
Qmodel df p Qresid df p 
Exercise volume .07 .31 7.32 1.0 .01 53.40 13.0 .00 
Baseline depression .06 .37 7.89 1.0 .01 49.32 13.0 .00 
Note. B = standardised beta coefficient of regression model; R2 = proportion of between-study variance 
explained; Qmodel = variability associated with regression model; Qresid = variability unaccounted for by the 






















The present systematic review evaluated the effects of exercise training interventions 
on depression severity scores in adults with MS.  Fifteen RCTs, comprising of 544 
participants, were meta-analysed to generate pooled effect size data.  The combined findings 
are promising: exercise training contributed to immediate and large statistically significant 
improvements in depression severity.  Further research is, however, needed to determine 
whether these treatment gains are maintained over time.  Although no significant differences 
between aerobic and nonaerobic types of exercise were noted, increased exercise volume and 
higher baseline depression severity scores were both significantly associated with depression 
alleviation.  The findings of the present study are critically evaluated below, including a 
discussion of clinical and research implications alongside associated methodological 
limitations.   
Effectiveness of Physical Exercise 
The finding that exercise training was associated with large and immediate reductions 
in depression severity compared with non-exercise controls, is consistent with evidence for 
the psychological and hormonal mechanisms underlying the alleviation of depression via 
exercise (Antunes et al., 2016; Haller et al., 2018; Legrand, 2014).  The noted treatment 
effects were also larger than the small to moderate pooled effects previously reported by 
meta-analyses examining exercise, which included uncontrolled studies using active controls, 
unsupervised interventions, or multidisciplinary programs, and their effectiveness in MS-
related depression (Dalgas et al., 2015; Ensari et al., 2014; Herring et al., 2017).  The present 
finding may, in part, be attributable to the inclusion of newly published studies.  Namely, two 
recently published RCTs (Bahmani et al., 2019; Negaresh et al., 2019) contributed moderate 
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to large, positive effects, which may reflect advances in training methods or the provision of 
increased guidance/technique advice from supervising therapists, to improve treatment 
effectiveness.  This large finding is, however, tempered by substantial heterogeneity and 
dispersion in effect sizes among the included studies, which suggests some imprecision in 
this estimate.  More specifically, seven studies found moderate to large significant effects, 
while the remaining eight studies found non-significant results.  The mixed evidence may be 
explained by use of varied sample sizes.  For example, the eight studies producing non-
significant results were typically pilot or feasibility trials and used smaller sample sizes in 
comparison to those finding significant effects.  The small sample sizes used in these eight 
studies meant they were potentially underpowered to detect the true treatment effects of 
exercise. 
Given that prior research indicates depression is a modifiable symptom of MS (Fiest 
et al., 2016; Herring et al., 2017), the results of this meta-analysis have some important 
clinical implications.  The results provide some direction for tailored starting and advanced 
level treatment recommendations.  In particular, the majority of interventions included in the 
present study were targeted at sedentary exercise levels.  For a chronic condition such as MS, 
improvements in depression might require that a person starts at a minimum level of training 
(i.e., twice or thrice weekly, 30-45 minute sessions; Bahmani et al., 2019; Briken et al., 2014; 
Dalgas et al., Negaresh et al., 2019) and then consider increasing the duration and volume of 
sessions over time, as their physical and mental endurance improves to show larger 
improvements (Razazian et al., 2015).  This might include a combination of either aerobic 
exercise, such as interval (i.e., efforts complemented with rest periods) or endurance training, 
or less cardiovascular intense nonaerobic exercise (e.g., yoga or resistance training), for at 
least 8-weeks (Bahmani et al., 2019; Briken et al., 2014; Dalgas et al., 2010; Negaresh et al., 
2019; Petajan et al., 1996; Razazian et al., 2015).   
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No firm conclusions can be drawn regarding longer-term effectiveness of exercise 
training, with mixed findings noted by the four studies that provided this information.  
Interestingly, the large and significant increase in depression severity shown at a 26-week 
follow-up (Learmonth et al., 2011) is consistent with the results of a prior review in healthy 
adults, whereby depression exacerbated after ceasing an exercise program (Morgan et al., 
2018).  This individual finding may indicate that exercise does not promote lasting 
improvement and requires sustained participation to maintain depression benefits, especially 
considering the control condition reported an improvement in mood comparatively.  It 
follows that the evidence found for the exercise-mediated psychological and hormone 
mechanisms for alleviating depression, may only result in short-term benefits (Amorosi, 
2014; Antunes et al., 2016; Haller et al., 2018; Legrand, 2014; Pickett et al., 2012).  Notably, 
the large and significant increase in depression seen at 26-weeks, reversed to a small 
improvement in depression at 52-weeks (Learmonth et al., 2011).  Although this latter follow-
up result was non-significant, it might indicate that depression and its symptoms can take 
time to alleviate due to the wide range of psychological, physical, and social contributors to 
low mood (Gay et al., 2010).  Therefore, routine assessment of longer-term (i.e., beyond 12 
months) depression outcomes is required in future research to draw firm conclusions 
regarding the longer-term effectiveness of exercise training and enable more specific 
treatment guidelines (e.g., how long the ‘exercise effect’ lasts before further treatment is 
required to sustain results).   
Interventions providing long-term improvements will offer the greatest benefit to 
persons with MS as they navigate their lifelong condition, particularly if exercise completed 
in earlier stages of the disease can protect against depression in later stages when physical 
activity may not be feasible due to exacerbated disability.  Treatment methods that are 
effective over time are also likely to appeal most to health providers when considering 
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implementation, not only for their low-maintenance nature, but also to minimise consultation 
frequency with patients (Kidd et al., 2017).  
Moderators of Treatment Effectiveness 
Between-group differences for aerobic and nonaerobic exercise were non-significant: 
the type of exercise did not affect the magnitude of depression reductions.  Although, aerobic 
interventions were associated with significant and moderate depression reductions.  This 
finding is consistent with prior research in the general population and may potentially be 
attributable to the ‘runner’s high’ phenomenon (production of endorphin hormones) 
associated with aerobic exercise to alleviate depression (Béland et al., 2020; Morres et al., 
2019).   
In all, this subgroup analysis was likely underpowered, which may have impeded 
production of reliable results.  Specifically, only three and eight studies were included in the 
nonaerobic and aerobic subgroups each respectively, which does not concord with 
recommendations of a minimum of 10 studies per subgroup from The Cochrane 
Collaboration (Higgins et al., 2019).  Notably, one study that was excluded from this analysis, 
due to sample overlap (i.e., a shared control group), administered a nonaerobic yoga 
intervention and produced a very large, significant depression severity reduction (Razazian et 
al., 2015).  Notably, this yoga intervention produced the largest individual effect of the study.  
There is, then, a need for further comparative research examining the relative benefits of each 
exercise type to better inform program design.  In particular, it is clinically important to 
determine if other forms of nonaerobic exercise, such as yoga, are as effective as strenuous 
cardiovascular styles of aerobic endurance training.  More specifically, lower impact training 
methods may appeal more to a typically sedentary population and enhance program 
adherence to ultimately improve mood (Martinsen et al., 1989).  Future research might also 
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consider the use of multiple control groups, particularly if more than one exercise 
intervention is being examined, to avoid issues of sample dependency. 
Exercise volume, operationalised as the total number of sessions over the course of a 
treatment, emerged as a key feature of program design that explained a significant portion of 
variance.  That is, larger volumes of exercise training were associated with larger depression 
reductions and indicative of a ‘dose-response’ relationship (Wasfy & Baggish, 2016).  This 
finding confirms preliminary evidence in the MS population (Herring et al., 2017).  The two 
studies associated with the largest reductions in depression administered exercise thrice 
weekly for 24 to 45 sessions over the course of treatment (Petajan et al., 1996; Razazian et 
al., 2015).  It follows that exercise prescription for persons with MS should involve larger 
volumes of exercise, over time, to optimise depression outcomes.  Further controlled research 
is required to identify the optimal volume for aerobic and nonaerobic exercise to further tailor 
recommendations.   
Baseline depression severity was also a crucial patient characteristic: higher scores at 
baseline were associated with larger immediate reductions in depression.  Taken at face value, 
those experiencing more severe depression exhibit greater capacity for change.  
Comparatively, those with lower severity scores may have reduced capacity for improvement 
due to an already ‘healthy’ status.  This finding is consistent with meta-analytic evidence for 
exercise in clinical samples (i.e., high levels of depression at baseline; Silveira et al., 2013).  
Although prior MS reviews suggest that baseline depression does not impact on resulting 
treatment change (Dalgas et al., 2015; Ensari et al., 2014; Herring et al., 2017), the present 
study included a higher relative proportion of candidates with increased capacity for change 
(i.e., those more severely depressed).  For example, 49% of candidates in the present study 
were classed as ‘depressed’ at baseline according to depression measure cut-off scores, 
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compared to 41%, 15%, and 41% in prior MS reviews, each respectively (Dalgas et al., 2015; 
Ensari et al., 2014; Herring et al., 2017). 
Although engagement with the interventions was generally high, as evidenced by the 
low overall rates of attrition, individual study results highlight a need to consider strategies to 
promote accessibility and potentially engagement.  Namely, two studies reporting higher rates 
of withdrawal (i.e., > 20%) revealed reasons related to issues of access, such as lack of time 
to commit to the program, competing family commitments, or the classes being located too 
far away (Learmonth et al., 2011; Oken et al., 2004).  Therefore, exercise could potentially be 
administered as a technology-based intervention, such as a smartphone or online app with 
supervised therapist sessions for live feedback, to increase the accessibility of guided and 
structured programs (i.e., avoid travel issues, increase choice of class times to work around 
commitments).  The effectiveness of internet-based exercise programs, including mobile 
health apps is demonstrated in the general population (Jahangiry et al., 2017).  More recently, 
use of the ‘Zoom’ app has become popular during the Covid-19 pandemic to deliver 
supervised and online group training interventions (Ng, 2020; Tison et al., 2020).  This 
method of delivery therefore appears to be a worthwhile endeavor to consider long-term in 
the MS population. 
Limitations 
The methodological limitations of the current findings must be considered in the 
context of data sourcing and extraction.  Firstly, the strict eligibility criteria may have 
inhibited the inclusion of all relevant studies, including that of grey literature.  Furthermore, 
potential studies must have made explicit reference to ‘multiple sclerosis’ or ‘exercise’—or 
their relevant synonyms—to be identified during the initial screening process.  This approach 
enabled objective, replicable, and systematic screening.  However, given the various terms 
used to describe specific exercise training methods, it is likely that relevant studies 
EXERCISE AND DEPRESSION IN MULTIPLE SCLEROSIS 
 
39 
administering exercise without making explicit reference to key terms were missed as a 
consequence (e.g., “aerobics” rather than “exercise”).  In an attempt to mitigate this 
limitation, broad search terms and their synonyms were adopted; however, more specific 
exercise terms were unable to be covered in searches due to the vast number of different 
training styles.   
The potential confounding role of sample characteristics also needs to be considered.  
For example, no study investigated MS patients with clinically confirmed diagnoses of MDD; 
rather, most patients falling in ‘severe’ symptom categories were excluded.  This likely 
resulted in an underpowered sample of depressed candidates with a greater capacity for 
change (Ensari et al., 2014), which may have underestimated the already large effect 
magnitude identified.  In addition, the proportion of variance explained by baseline 
depression may also have been underestimated.  Future studies should include more 
participants with MDD, or those falling in severe symptom ranges to increase generalisability 
of the results to clinical cases of MS-related depression.   
A further limitation was the failure of some studies to control for participant exercise 
levels prior to the intervention.  Although the majority of the MS population is sedentary 
(Blikman et al., 2015), most studies included participants with mild to moderate disease 
severities of whom prior exercise activity was possible.  For example, if participants were 
engaged in recent, prior exercise programs that were effective at reducing depression, 
additional improvements may not have been produced from the study interventions.  Future 
RCTs should routinely consider prior activity levels when defining the eligible sample to 
enable more reliable treatment effect estimates. 
The operationalisation of ‘exercise volume’ in this review might also have been 
problematic.  Ideally, exercise dose is determined by three variables: duration, frequency, and 
intensity (Wasfy & Baggish,2016).  Despite the ability of the present study to quantify 
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duration and frequency, the majority of studies did not formally report exercise intensity - 
which research has shown may influence depression reduction (Balchin et al., 2016).  
Therefore, future intervention research should make explicit all exercise dosage variables in 
order to provide more complete exercise recommendations.   
It follows that there were limitations in the context of intervention delivery.  In all, the 
majority of studies administered exercise as a group intervention.  Despite the clear benefits 
for maximising resources (i.e., use of a therapist for one as opposed to many individual 
sessions), it is possible the socialisation afforded by group training may have confounded 
resulting depression scores, considering that social support is a variable also linked to 
improved depression (Cruwys et al., 2013).  Social support may have augmented the large 
results found and promoted exercise adherence as a result (Çakit et al., 2010).  Future RCTs 
should consider using attention controls or measures of social support to control for and 
enable investigation of the potential impact of socialisation (Bahmani et al., 2019; Razazian 
et al., 2015; Sutherland et al., 2001), 
Lastly, there was also some variation in the post-test data relating to socialisation 
effects.  Although most studies generated immediate effect estimates from mean differences 
between baseline and post-intervention depression scores, Sutherland and colleagues (2001) 
took measurements at baseline and week-8 of the 10-week program.  This was an attempt to 
control for the negative effect on psychological health shown in prior research from 
anticipation of the end of the program and removal of social support from exercising in a 
group (Petajan et al., 1996).  However, this may have led to an underestimated effect 
estimate—as reinforced by the trim-and-fill results indicating the pooled effect was 
underestimated—if the already discovered moderate reductions continued to improve in the 
remaining 2-weeks.  Instead, future studies may consider referring participants to support 
groups upon nearing study completion in attempt to mitigate the social aspect of this concern.  




The results of the present study provide evidence for the effectiveness of exercise 
training to improve depression symptom severity, at least in the short-term, among persons 
with MS.  In particular, the effect of exercise is maximised by targeting those with higher 
baseline depression: a subgroup most prone to respond due to their increased capacity for 
change.  In addition, improvements in depression severity are augmented by bolstering the 
session volume and duration; specifically, sessions as frequent as thrice weekly for 8-weeks 
reported the largest improvements.  Future research can extend on the present findings by 
focusing on clinically depressed persons with MS, further comparing aerobic and nonaerobic 
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Appendix A: Logic Grids 
 
Table A.1 
Logic Grid for Cochrane Library 
Exercise                                      AND Multiple Sclerosis 
exercise  
OR  




endurance training  
OR  
resistance training  
OR  
high-intensity interval training  
OR  
athletic performance  
OR  
movement therapy  
OR  
occupational therapy  
OR  
















Note. The ‘title, abstract, keyword’, ‘in trials’, and ‘word variation’ options were selected. No date 
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Table A.2  
Logic Grid for Embase 





“athletic performance”:ti,ab  
OR 
 “endurance training”:ti,ab  
OR 
 “high intensity interval training”:ti,ab  
OR 
 “athletic training”:ti,ab  
OR  
“movement therapy”/de  
OR  
“movement therapy”:ti,ab  
OR 
“occupational therapy”/de  
OR  
“occupational therapy”:ti,ab  
OR 
“physical activity”/exp  
OR  
“physical activity”:ti,ab  
OR  








 “resistance training”:ti,ab  
 
“multiple sclerosis”/de  
OR 
“multiple sclerosis”:ti,ab  
OR 




“demyelinating disease”/de  
OR 
 “demyelination”/de  
 
Note. Under ‘mapping’ options, only ‘map to preferred term in Emtree’ was selected. No date or 
language filters were applied. Search yielded 8155 results.  
 
 
Table A.3  
Logic Grid for PEDro  
Exercise                                      AND Multiple Sclerosis 
exercise  multiple sclerosis 
 
Note. The advanced search option was used, and “exercise AND multiple sclerosis” was inserted 
into the ‘Abstract and title’ search option. The ‘clinical trial’ option was selected for the ‘method’ 
category. No date or language filters were applied. Search yielded 189 results. 
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Table A.4  
Logic Grid for PsycINFO 
Exercise                                      AND Multiple Sclerosis 
exp exercise  
OR  
exercis* mp  
OR  
movement therap*.mp  
OR  
movement therapy.sh  
OR 
physical activit*.mp  
OR  
physical activity.sh  
OR 
athletic performance.sh  
OR  
athletic performance mp  
OR 
athletic training.mp  
OR 
athletic training.sh  
OR 
exp occupational therapy  
OR  
occupational therap*.mp  
OR 
physical therap*.mp  
OR 
physical therapy.sh  
OR 
exp physical endurance  
OR  
physical endurance mp  
OR 
physical exertion.mp  
OR 
exp physical therapy  
OR  




exp multiple sclerosis  
OR  
multiple sclerosis.mp  
OR 
disseminated sclerosis.mp  
OR 
demyelinating disorder*.mp  
OR 
demyelinating disease* mp  
OR 
exp demyelination  
OR  
demyelinating autoimmune disease*.mp  
 
Note. Two basic searches were conducted for each category and combined using the “AND” 
feature. The ‘map search term to search heading’ filter was selected, while ‘produced the same 
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Table A.5  
Logic Grid for PubMed  





physical conditioning[tiab]  
OR 
resistance training[tiab] OR 
“athletic performance”[mh]  
OR 
athletic performance[tiab]  
OR 
physical endurance[tiab]  
OR 
physical activit*[tiab]  
OR 
“physical exertion”[mh]  
OR 
physical exertion[tiab]  
OR 
“recreation therapy”[mh]  
OR 
recreation therap*[tiab]  
OR 
“physical therapy modalities”[mh:noexp]  
OR 
“exercise therapy”[mh]  
OR 
physical therap*[tiab]  
OR 
endurance training[tiab]  
OR 
resistance training[tiab]  
 
“multiple sclerosis”[mh]  
OR 
multiple sclerosis[tiab]  
OR 
“demyelinating diseases”[mh:noexp]  
OR 




demyelinating disorder[tiab]  
OR  
demyelinating disease[tiab]  
 
Note. The advanced search option was used, applying the ‘clinical trials’ filter. No date or language 
filters were applied. Search yielded 470 results. 
 
EXERCISE AND DEPRESSION IN MULTIPLE SCLEROSIS 
 
68 
Appendix B: Depression Measures 
Table B 
Included Validated Depression Measures, Severity Classifications and Clinical Cut-Off 
Scores 
Measure Abbreviation Range Classification 
Clinical 
cut-off 
Beck Depression Inventory  BDI 0–63 0–9: Minimal 
10–19: Mild 
20–30: Moderate-severe 
≥ 31: Severe 
 
12 
Beck Depression Inventory 
– Second Edition  






Beck Depression Inventory 
– Fast Screen for Medical 
Patients  






Center for Epidemiologic 
Studies Depression Scale – 
Boston (short form) 
 
CES-D-10 0–30 - 15 
Hospital Anxiety and 
Depression Scale – 
Depression subscale 






Self-Rated Inventory of 
Depressive Symptoms 
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Measure Abbreviation Range Classification 
Clinical 
cut-off 
Major Depression Inventory  MDI 0–50 20–24: Mild 
25–29: Moderate 
≥ 30: Severe 
 
21 
Profile of Mood States – 
Depression subscale  
POMS-D 0–60 - 
 
- 
Profile of Mood States Short 
Form – Depression Subscale 
POMS-SF D 0–32 - - 








≥ 21: Very severe 
13 
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Appendix C: PRISMA Checklist 
Table C 
Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Checklist (Moher et al., 2009) 
Section/topic # Checklist item Reported on 
page # 
TITLE    
Title 1 Identify the report as a systematic review, meta-analysis, or both. Title pg. 
ABSTRACT    
Structured 
summary 
2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of 
key findings; systematic review registration number. 
v 
INTRODUCTION    
Rationale 3 Describe the rationale for the review in the context of what is already known. 6-9 
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS). 
9-10 
METHODS    
Protocol and 
registration 
5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration 
information including registration number. 
- 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, 




7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional 
studies) in the search and date last searched. 
11, 18 
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated. 64-67 





10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for 
obtaining and confirming data from investigators. 
13, 73 
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Section/topic # Checklist item Reported on 
page # 
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made. 
14 
Risk of bias in 
individual studies 
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the 




13 State the principal summary measures (e.g., risk ratio, difference in means). 15 
Synthesis of 
results  
14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) 
for each meta-analysis. 
15-16 
Risk of bias across 
studies 





16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which 
were pre-specified. 
17 
RESULTS    
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each 








Risk of bias 
within studies 
19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12). 24-25, 77 
Results of 
individual studies 
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group 




21 Present results of each meta-analysis done, including confidence intervals and measures of consistency. 26-31 
Risk of bias across 
studies 
22 Present results of any assessment of risk of bias across studies (see Item 15). 24-25, 77 
Additional 
analysis  
23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]). 31-32 
DISCUSSION     
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24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key 
groups (e.g., healthcare providers, users, and policy makers). 
33-38 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified 
research, reporting bias). 
38-40 
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  33-38, 40 
FUNDING    
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Study characteristics  
Total N  













Intervention demographics  




M: ________  SD: ________   
 
Intervention MS characteristics 
Time since diagnosis (years):  
M: ________  SD: ________   
Type: CIS, RR, P (SP, PP)  
CIS (N):  




M: ________  SD: ________   
Exercise intervention:  
Sessions (per week): __________ 
Session duration (mins): _______ 
Treatment length (weeks): _____ 
Mode: ______________________ 
____________________________ 







Intervention effect size data 
Outcome: ___________________ 
Sample size: _________________ 
Pre intervention outcome score: 
M: ________  SD: ________   
Post intervention outcome score: 
M: ________  SD: ________   
Other data (e.g. g, 95% CI’s if 











Control type: ________________ 




M: ________  SD: ________   
 
MS characteristics 
Time since diagnosis (years): 
 M: ________  SD: ________   
Type: CIS, RR, P (SP, PP)  
CIS (N):  




M: ________  SD: ________   
 
Control effect size data 
Outcome: ___________________ 
Sample size: _________________ 
Pre intervention outcome score: 
M: ________  SD: ________   
Post intervention outcome score: 
M: ________  SD: ________   
Other data (e.g. g, 95% CI’s if 
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Extracted from Maher et al. (2003).
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Appendix F: Included Study Details 
Table F 
Study Characteristics and Demographics 
Lead author (year) Country Measure N 
Age (years) 





Disease Duration (years) 
(M ± SD) 
EDSS 
(M ± SD) 
Depressed 
(%) 
Ahmadi (2013) Iran BDI 31 35.26 (9.01) 100.0 - 5.12 (4.09) 2.22 (1.16) 35.48 
Bahmani (2019) Iran BDI-FS 47 37.93 (9.15) 100.0 - 7.07 (6.63) 2.24 (1.65) 100.0 
Briken (2014) Germany IDS-SR30 42 49.75 (7.83) - - 15.85 (7.34) 4.95 (.84) 0.0 
Çakit (2010) Turkey  BDI 30 35.95 (10.53) - - 7.9 (4.07) - 100.0 
Dalgas (2010) Denmark  MDI 31 48.4 (9.29) - 100.0 7.35 (5.9) 3.8 (.89) 0.0 
Fleming (2019) Ireland  1) HADS-D 
2) QIDS 
3) POMS-D 
9 52.55 (6.8) 100.0 - - - 1) 33.33 
2) 0.0 
3) - 
Hebert (2011)  US BDI-II 26 46.4 (10.37) 84.62 88.46 7.1 (5.89) - 0.0 
Learmonth (2011) Scotland  HADS-D 32 51.6 (7.91) 71.88 - 13.0 (6.97) 5.98 (.44) 0.0 
Miller (2011)  Scotland  HADS-D 30 54.6 (7.83) 63.33 0.0 15.85 (8.95) 7.05 (.66) 0.0 
Negaresh (2019) Iran BDI 61 31.12 (3.06) 65.57 100.0 7.33 (3.53) 1.6 (.93) 100.0 
Oken (2004) US 1) CES-D-10 
2) POMS-D 
57 49.0 (8.74) 92.98 - - 3.07 (1.82) 1) 0.0 
2) - 
Petajan (1996) US POMS-D 46 40.05 (2.11) 67.39 - 7.75 (2.05) 3.35 (.54) - 
Razazian (2015) Iran BDI 54 33.94 (6.92) 100.0 66.67 6.93 (.82) 3.53 (1.09) 100.0 
Sutherland (2001) Australia POMS-SF D 22 46.32 (4.87) 54.55 - 6.59 (4.61) - - 
Tollár (2020)  Hungary  BDI 26 46.25 (6.34) 92.31 65.38 13.6 (4.21) - 100.0 
  Total 544 43.94 (7.55) 82.77 73.68 9.34 (3.77) 3.78 (1.74) 48.74 
Note. M = mean; SD = standard deviation; F = female gender; RRMS = Relapsing-remitting MS; EDSS = Expanded Disability Status Scale; % Depressed = percentage of participants exceeding clinical cut-off 
score at baseline; (-) = data not provided. Depression measures: POMS-D = Profile of Mood States – Depression Subscale; IDS-SR30 = Self-Report Quick Inventory of Depression Symptomology; BDI = Beck 
Depression Inventory; BDI-FS = Beck Depression Inventory – Fast Screen for Medical Patients; MDI = Major Depression Inventory; POMS-SF-D = Profile of Mood States Short Form – Depression Subscale; 
HADS-D = Hospital Anxiety and Depression Scale – Depression Subscale; CES-D-10 = Centre for Epidemiologic Studies Depression Scale – Boston (Short form); BDI-II = Beck Depression Inventory – Second 
Edition; QIDS- SR16 = Quick Inventory of Depressive Symptomology. 
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Appendix G: Individual Risk of Bias Assessment 
Table G 
Reporting Quality of Included Studies Based on the PEDro Scale (Nstudies = 15) 








































































































































































































Ahmadi (2013) 1 1 0 1 0 0 0 1 1 1 1 
Bahmani (2019) 1 1 1 1 0 0 1 0 0 1 1 
Briken (2014) 1 1 1 1 0 0 0 1 0 1 1 
Çakit (2010) 1 1 0 1 0 0 1 0 0 1 1 
Dalgas (2010) 1 1 1 1 0 0 0 1 0 1 1 
Fleming (2019) 1 1 1 1 0 0 0 0 0 0 1 
Hebert (2011) 1 1 1 1 0 0 0 1 1 1 1 
Learmonth (2011) 1 1 0 1 0 0 1 0 1 1 1 
Miller (2011) 1 1 1 1 0 0 1 1 0 1 1 
Negaresh (2019) 1 1 1 1 0 0 1 1 0 1 0 
Oken (2004) 1 1 0 1 0 0 1 0 0 1 1 
Petajan (1996) 1 1 0 1 0 0 0 1 0 1 1 
Razazian (2015) 1 1 1 1 0 0 1 0 1 1 1 
Sutherland (2001) 1 1 0 1 0 0 0 1 1 1 1 
Tollár (2020) 1 1 1 1 0 0 1 1 0 1 1 
 
Scoring note: 1 = criterion met, 0 = criterion not met. 
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Appendix H: Univariate Meta-Regression Scatterplots 
Figure H.1  
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Figure H.2  
Univariate Meta-Regression to Examine Baseline Depression Scores 
 
